Featured News
Press Release
Senate Unanimously Passes BOLD Legislation to Strengthen Nation’s Dementia Public Health Infrastructure
Washington, D.C., November 21, 2024 — The U.S. Senate unanimously passed the BOLD Infrastructure for Alzheimer’s Reauthorization Act, bipartisan legislation spearheaded by the Alzheimer’s Association ...
All News
Press Release
FDA Advisory Committee Unanimously Confirms Efficacy and Clinical Benefit of Leqembi for Early Alzheimer's Disease
CHICAGO, June 9, 2023 — Today, an Advisory Committee to the Food and Drug Administration (FDA) unanimously endorsed the efficacy...
AIM Blog
Recognizing AIM’s June Advocate of the Month: Mike Razzi
Each month, we’re featuring an advocate who engages with policymakers to ensure priorities that improve the lives of people impacted...
Press Release
Alzheimer’s Association Statement on CMS Announcement of Registry for Access to FDA-Approved Alzheimer’s Treatments
The Alzheimer’s Association recognizes that the Centers for Medicare & Medicaid Services (CMS) has announced their conceptual approach to fulfill...
Press Release
Alzheimer’s Association Statement on Announcement of Rosalynn Carter’s Dementia Diagnosis
The Alzheimer’s Association expresses our deepest appreciation to former First Lady Rosalynn Carter and her family for sharing her diagnosis...
AIM Blog
Alzheimer’s Advocates Rally for CMS to “Fix This Mess” and Stop Blocking Access to Alzheimer’s Treatments
In communities across the nation, passionate Alzheimer’s advocates put on their purple, picked up their signs and rallied for access...
Press Release
Alzheimer’s Association, Individuals Living with Alzheimer’s Urge FDA to Grant Traditional Approval for Lecanemab
CHICAGO, May 25, 2023 — The Alzheimer's Association and members of the Association's Early Stage Advisory Group submitted comments to...